Close
 

Figure 2: (a) Progression-free survival analysis of the gemcitabine and docetaxel groups. (b) Overall survival analysis of the gemcitabine and docetaxel groups. Kaplan–Meier survival analysis

Figure 2: (a) Progression-free survival analysis of the gemcitabine and docetaxel groups. (b) Overall survival analysis of the gemcitabine and docetaxel groups. Kaplan–Meier survival analysis